• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Third party research

Sparekassen Sjælland-Fyn: Q1 2022 first impression, More of a mixed bag - Nordea

SJF Bank

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Q1 2022 PBLL came in DKK 31 (21%) below our estimate, mainly led by a DKK 25m miss on low quality market value adjustments. Main positive is key income lines; NII came in at DKK 146m, DKK 3m (2%) ahead of our estimate, while NCI was in line with our estimate and 7% up y/y. Total business volumes (including DLR- and Totalkredit credit lines) continued a positive trajectory in Q1 2022, but bank lending was flattish (and thus below peers and our expectations).Total cost came in DKK 11m (6%) above (thus, worse than) our estimate. Impairment charges represented a small income in Q1 2022. CET1 ratio was 16.2%. We estimated 17.2%. The 2022 guidance is left unchanged (pre-tax proft DKK 385-510m). We estimate DKK 489m. Overall, the report is more of a mixed bag in our view. We are likely to make negative EPS revisions for 2022E of 4-6% while we are likely to reduce 2023E-2024E EPS 3-4%. The share is likely to trade somewhat below peers.